This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vajkoczy, P. Articles by Schmiedek, P. Search for Related Content PubMed PubMed Citation Articles by Vajkoczy, P. Articles by Schmiedek, P. Related Collections Acute Cerebral Infarction Brain Circulation and Metabolism Primary and Secondary Stroke Prevention Aneurysm, AVM, hematoma

(Stroke. 2001;32:498.)
© 2001 American Heart Association, Inc.

Original Contributions

Effect of Intra-Arterial Papaverine on Regional Cerebral Blood Flow in Hemodynamically Relevant Cerebral Vasospasm

Peter Vajkoczy, MD; Peter Horn, MD; Christian Bauhuf, MD; Elke Munch, MD; Ulrich Hubner; Dipl Ing; Claudius Thome, MD; Christiane Poeckler-Schoeninger, MD; Harry Roth, MD Peter Schmiedek, MD

From the Departments of Neurosurgery (P.V., P.H., C.B., U.H., P.S.), Anesthesiology (E.M., H.R.), and Radiology (C.P-S.), Klinikum Mannheim, University of Heidelberg, Mannheim, Germany.

Correspondence to Dr P. Vajkoczy, Department of Neurosurgery, Klinikum Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany. E-mail peter.vajkoczy{at}nch.ma.uni-heidelberg.de

Background and Purpose—It remains controversial whether the intra-arterial administration of papaverine (IAP) is effective in reversing vasospasm-associated cerebral hypoperfusion after aneurysmal subarachnoid hemorrhage. The aim of the present study was to continuously assess regional cerebral blood flow (rCBF) during and after IAP with the use of quantitative, bedside thermal diffusion flowmetry.

Methods—Eight patients with cerebral vasospasm after subarachnoid hemorrhage (mean flow velocity >120 cm/s; angiographic vessel constriction >33%; hemispheric cerebral blood flow [CBF] <32 mL/100 g per minute) were prospectively entered into the study. Before IAP, thermal diffusion microprobes were implanted into the white matter of each affected vascular territory (n=10) for rCBF monitoring. During and after IAP (300 mg papaverine/50 mL saline over 1 hour), mean arterial blood pressure, intracranial pressure, cerebral perfusion pressure, thermal diffusion rCBF (TD-rCBF), and cerebrovascular resistance (CVR) were recorded continuously.

Results—IAP significantly increased TD-rCBF from 7.3±1.6 to 37.9±6.6 mL/100 g per minute (mean±SEM), indicating reversal of cerebral hypoperfusion. This TD-rCBF response was dependent on the degree of cerebral vasospasm and reduced perfusion within the vascular territory. Long-term analysis of TD-rCBF, however, demonstrated that this beneficial effect of IAP on cerebral hypoperfusion was only transient: within 3 hours after treatment, TD-rCBF and CVR returned to baseline values. Furthermore, a lack of correlation between transcranial Doppler sonography and thermal diffusion flowmetry suggested that transcranial Doppler sonography is not suited for CBF-based neuromonitoring after IAP.

Conclusions—IAP is not effective in permanently reversing cerebral hypoperfusion in patients with cerebral vasospasm. The need to validate alternative therapeutic strategies that seek to improve cerebral perfusion in vasospasm warrants continued development of CBF-based neuromonitoring strategies.

Key Words: cerebral circulation • ischemia • microcirculation • stroke

This article has been cited by other articles:

				D. Hanggi, B. Turowski, K. Beseoglu, M. Yong, and H.J. Steiger Intra-Arterial Nimodipine for Severe Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Influence on Clinical Course and Cerebral Perfusion AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1053 - 1060. [Abstract] [Full Text] [PDF]

				H.-J. Priebe Aneurysmal subarachnoid haemorrhage and the anaesthetist Br. J. Anaesth., July 1, 2007; 99(1): 102 - 118. [Abstract] [Full Text] [PDF]

				A. Biondi, G. K. Ricciardi, L. Puybasset, L. Abdennour, M. Longo, J. Chiras, and R. Van Effenterre Intra-Arterial Nimodipine for the Treatment of Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Preliminary Results AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 1067 - 1076. [Abstract] [Full Text] [PDF]

				N. Badjatia, M. A. Topcuoglu, J. C. Pryor, J. D. Rabinov, C. S. Ogilvy, B. S. Carter, and G. A. Rordorf Preliminary Experience with Intra-Arterial Nicardipine as a Treatment for Cerebral Vasospasm AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 819 - 826. [Abstract] [Full Text] [PDF]

				D J A Connolly, D Birchall, and A Gholkar Current theory in imaging of intracranial vascular disease Imaging, October 1, 2002; 14(5): 396 - 408. [Abstract] [Full Text] [PDF]

				L. Feng, B.-F. Fitzsimmons, W. L. Young, M. F. Berman, E. Lin, B. D. L. Aagaard, H. Duong, and J. Pile-Spellman Intraarterially Administered Verapamil as Adjunct Therapy for Cerebral Vasospasm: Safety and 2-Year Experience AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1284 - 1290. [Abstract] [Full Text] [PDF]

				Mechanical and Pharmocologic Treatment of Vasospasm AJNR Am. J. Neuroradiol., September 1, 2001; 22(2007): 26S - 27S. [Full Text] [PDF]